NAME Dr Ashleigh Poh
CANCER TYPE Pancreatic cancer
INSTITUTION Olivia Newton-John Cancer Research Institute
GRANT TYPE $50,000
PROJECT TYPE Research
Targeting macrophages to treat pancreatic cancer growth and metastasis
This research project will define the therapeutic benefit of targeting Haematopoietic Cell Kinase (HCK) in advanced-stage pancreatic cancer. This aims is to provide novel molecular insights into therapeutically targetable mechanisms by which macrophages promote pancreatic cancer progression, and deliver better therapeutic options to pancreatic cancer patients.